Pitfalls in the diagnosis of mitochondrial encephalopathy with lactic acidosis and stroke-like episodes

Journal of Neuro-Ophthalmology

Volumn 26, Issue 1, 2006, Pages 38-43

  Mizrachi, Iris Ben Bassat ^a   Gomez Hassan, Diana ^b   Blaivas, Mila ^b   Trobe, Jonathan D ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; BRAIN BIOPSY; BRAIN ISCHEMIA; CASE REPORT; CEREBROVASCULAR ACCIDENT; CONFUSION; DIABETES MELLITUS; DIAGNOSTIC ERROR; DISORIENTATION; DNA DETERMINATION; ECHOLALIA; ELECTROENCEPHALOGRAM; ENCEPHALOMALACIA; EYE MOVEMENT; FATIGUE; HEADACHE; HEMISPHERE; HUMAN; LETHARGY; MALE; MELAS SYNDROME; MUSCLE WEAKNESS; NEEDLE BIOPSY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCEPTION DEAFNESS; PHYSICAL EXAMINATION; POINT MUTATION; PRIORITY JOURNAL; SHORT STATURE; TENDON REFLEX; VASTUS LATERALIS MUSCLE; VISUAL DISORDER; VOMITING; BIOPSY; BRAIN; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAPHY; FOLLOW UP; LACTIC ACIDOSIS; METHODOLOGY; MITOCHONDRIAL ENCEPHALOMYOPATHY; PATHOLOGY;

ACIDOSIS, LACTIC; ADULT; BIOPSY; BRAIN; CEREBROVASCULAR ACCIDENT; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MITOCHONDRIAL ENCEPHALOMYOPATHIES;

EID: 33646823803     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wno.0000204662.25935.8b     Document Type: Article

References (30)

1. Hirano M, Pavlakis SG. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes MELAS: current concepts. J Child Neurol 1994;9:4-13.
2. Hirano M, Ricci E, Koenigsberger MR. MELAS: an original case and clinical criteria for diagnosis. Neuromasc Disord 1992;2:125-3.
3. Goto Y, Horai S, Matsuoka T, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutations. Neurology 1992;42:545-50.
4. Matthews PM, Tampieri D, Berkovic ST, et al. Magnetic resonance imaging shows specific abnormalities in MELAS syndrome. Neurology 1991;41:1043-6.
5. Apostolova LG, White M, Moore SA, et al. Deep white matter pathologic features in watershed regions. A novel pattern of central nervous system involvement in MELAS. Arch Neurol 2005;62:1154-6.
6. Castillo M, Kwock L, Green C. MELAS syndrome: imaging and proton MR spectroscopic findings. AJNR Am J Neuroradiol 1995;16:233-9.
7. Barkovich AJ, Good WV, Koch TK, et al. Mitochondrial disorders: analysis of their clinical and imaging characteristics. AJNR Am J Neuroradiol 1993;14:1119-37.
8. Oppenheim C, Galanaud D, Samson Y, et al. Can diffusion weighted magnetic resonance imaging help differentiate stroke from stroke-like events in MELAS? J Neurol Neurosurg Psychiatry 2000;69:248-50.
9. Kolb SJ, Costello F, Lee AG, et al. Distinguishing ischemic stroke from stroke-like lesions in MELAS using apparent diffusion coefficient mapping. J Neurol Sciences 2003;216:11-5.
10. Yonemura K, Hasegawa Y, Kimura K, et al. Diffusion-weighted MR imaging in a case of mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. AJNR Am J Neuroradiol 2001;22:269-72.
11. Ohshita T, Oka M, Imon Y, et al. Serial diffusion-weighted imaging in MELAS. Neuroradiology 2000;42:651-6.
12. Yoneda M, Maeda M, Kimura H. Vasogenic edema on MELAS: a serial study with diffusion-weighted MR imaging. Neurology 1999;53:2182-4.
13. Majoie CB, Akkerman EM, Blank C. Mitochondrial encephalomyopathy: comparison of conventional MR imaging with diffusion-weighted and diffusion tensor imaging: case report. AJNR Am J Neuroradiol 2002;23:813-6.
14. Osborn AG. Metabolic/degenerative disorders, inherited. In: Osborn AG, Blaser S, Salzman KL. Diagnostic Imaging: Brain. Salt Lake City, Utah: Amirsys Inc.; 2004:16-19.
15. Thambisetty M, Newman NJ. Diagnosis and management of MELAS. Expert Rev Mol Diagn 2004;4:631-44.
16. Wang XY, Noguchi K, Takashima S, et al. Serial diffusion-weighted imaging in a patient with MELAS and presumed cytotoxic edema. Neuroradiology 2003;45:640-3.
17. Powers JM, de Vivo DC. Peroxisomal and mitochondrial disorders. In: Graham DI, Lantos PL, eds. Greenfield's Neuropathology. Vol. I. London: Arnold; 2002:780-784.
18. Sparaco M, Bonilla E, DiMauro S, et al. Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropath Exp Neurol 1993;52:1-10.
19. Prayson RA, Wang N. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome: an autopsy report. Arch Pathol Lab Med 1998;122:978-81.
20. Kishi M, Yamamura Y, Kurihara T, et al. An autopsy case of mitochondrial encephalomyopathy: biochemical and electron microscopic studies of the brain. J Neurol Sci 1988;86:31-40.
21. Anderson JC, Costantino MM, Stratford T. Basal ganglia: anatomy, pathology, and imaging characteristics. Curr Probl Diagn Radiol 2004;33:28-41.
22. Avrahami E, Cohn DF, Feibel M, et al. MRI demonstration and CT correlation of the brain in patients with idiopathic intracerebral calcification. J Neurol 1994;241:381-4.
23. Henkelman RM, Watts JF, Kucharczyk W. High signal intensity in MR images of calcified brain tissue. Radiology 1991;179:199-206.
24. Osborne AG. Diagnostic Neuroradiology. St. Louis, MO: Mosby; 1994:777.
25. Brannan TS, Burger AA, Chaudhary MY. Bilateral basal ganglia calcifications visualized on CT scan. J Neurol Neurosurg Psych 1980;43:403-6.
26. Cohen CR, Duchesneau PM, Weinstein MA. Calcification of the basal ganglia as visualized by computed tomography. Radiology 1980;134:97-9.
27. Moller HE, Kurlemann G, Putzler M, et al. Magnetic resonance spectroscopy in patients with MELAS. J Neurol Sci 2005;229-230:131-9.
28. Abe K, Yoshimura H, Tanaka H, et al. Comparison of conventional and diffusion-weighted MRI and proton MR spectroscopy in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like events. Neuroradiology 2004;46:113-7.
29. Castillo M, Kwock L, Mukherji SK. Clinical application of proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:1-15.
30. Tanahashi C, Nakayama A, Yoshida M, et al. MELAS with the mitochondrial DNA 3243 point mutation: a neuropathological study. Acta Neuropathol 2000;99:31-8.